Loopbaan van John D. Weinberg
Eerdere bekende functies van John D. Weinberg
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MAAT PHARMA | Hoofd Techniek/Wetenschap/O&O | 01-07-2020 | 01-06-2022 |
| VELOXIS PHARMACEUTICALS A/S | Operationeel Directeur | 01-07-2010 | 29-02-2016 |
| Public Communications Contact | 02-06-2011 | 29-02-2016 | |
| Corporate Officer/Principal | 24-05-2012 | 07-06-2013 | |
| ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2005 | 01-01-2005 |
| 4D PHARMA PLC | Hoofd Techniek/Wetenschap/O&O | 01-06-2017 | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - | - |
Opleiding van John D. Weinberg
| University of the Witwatersrand | Doctorate Degree |
| INSEAD | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Frankrijk | 3 |
| Denemarken | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| MAAT PHARMA | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Beurs
- Insiders
- John D. Weinberg
- Ervaring
